Hepatitis B News and Research

Latest Hepatitis B News and Research

CDC data shows a sharp decrease in HIV testing during first year of COVID-19 pandemic

New CDC data published ahead of National HIV Testing Day (Monday, June 27) show a sharp decrease in the number of CDC-funded HIV tests administered in health care and non-health-care settings (43% and 50%, respectively) from 2019 to 2020, the first year of the COVID-19 pandemic.

28 Jun 2022

New tissue model helps trace the steps involved in liver regeneration

The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months.

27 Jun 2022

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.

27 Jun 2022

Chemically modified rocaglates have a stronger effect against viral replication

Hepatitis E virus (HEV) is widespread, and so far there is no effective drug. In the search for one, the so-called rocaglates have come into focus: plant compounds that can inhibit the replication of viruses.

27 Jun 2022

Simple blood test can predict liver cancer risk in NAFLD patients

An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can cause chronic inflammation and liver damage, increasing the risk of liver cancer.

22 Jun 2022

Researchers identify the role of TREM2-positive macrophages in non-alcoholic fatty liver disease

A MedUni Vienna study team has identified the role of a specific subtype of macrophages (white blood cells) in progressive non-alcoholic fatty liver disease.

21 Jun 2022

UB program secures $12.8 million to improve the quality of global HIV research

The National Institutes of Health (NIH) has awarded $12.8 million to the University at Buffalo School of Pharmacy and Pharmaceutical Sciences to lead a clinical pharmacology quality assurance program for NIH-funded laboratories and research networks across the globe conducting HIV and infectious disease research.

16 Jun 2022

Obesity causes COVID vaccines to lose their efficacy more rapidly

In a recent study posted to the medRxiv* pre-print server, researchers examined a clinical cohort of severely obese people vaccinated with coronavirus disease 2019 (COVID-19) vaccines to determine the relationship between an individual's body mass index (BMI) and COVID-19-related hospitalization and mortality.

16 Jun 2022

Will the US overcome its covid complacency even as the threat returns?

A few months ago, it seemed as though the country was poised to finally tame the pandemic, after two years of restrictions and tens of billions in government spending.

15 Jun 2022

Study shows alarming trends in mortality from alcoholic cirrhosis in the U.S.

Alcoholic cirrhosis is an advanced form of alcohol-related liver disease. In the United States between 2010 and 2016, alcohol-related liver disease was the primary cause of nearly 1 in 3 liver transplants, surpassing hepatitis C.

14 Jun 2022

As Biden fights overdoses, harm reduction groups face local opposition

Casey Malish had just pulled into an intersection in the 2nd Ward when a woman with tattoos and pinkish hair unexpectedly hopped into the back seat of his gray Mazda. He handles outreach for the Houston Harm Reduction Alliance, a nonprofit that helps drug users like her stay alive.

14 Jun 2022

Multi-national scientific task force needed to monitor zoonotic viruses long-term

A new study aimed to identify the main host, intermediate hosts, as well as other animal reservoirs for both SARS-CoV-2 and the monkeypox virus.

13 Jun 2022

Covid funding pries open a door to improving air quality in schools

Many U.S. schools were in dire need of upgrades — burdened by leaking pipes, mold, and antiquated heating systems — long before the covid-19 pandemic drew attention to the importance of indoor ventilation in reducing the spread of infectious disease.

13 Jun 2022

The potential role of Ginkgo biloba L. folium extract in the management of COVID-19

Researchers explored the effectiveness of Ginkgo biloba L. folium extract (EGb) in the management of COVID-19 severity.

13 Jun 2022

Co-circulation of adenovirus 40/41 and SARS-CoV-2 and emergence of hepatitis cases in children

In a recent study posted to the medRxiv* pre-print server, KU Leuven researchers investigated whether there was an association between the intensity of the co-circulation of adenovirus (AdV) 40/41 and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with the number of hepatitis cases of unknown origin emerging in Belgium.

12 Jun 2022

Study investigates SARS-CoV-2 escape from nirmatrelvir

Researchers assessed SARS-CoV-2 Alpha, Delta, and Omicron variants’ resistance to nirmatrelvir, a protease inhibitor of SARS-CoV-2.

10 Jun 2022

Etiologies of liver cancer are changing and the prognosis is mixed, study says

The primary causes of liver cancer are well known: viral (hepatitis B and C), alcohol and non-alcoholic steatohepatitis (NASH), a condition in which fat builds up in the liver, resulting in chronic inflammation and damage.

7 Jun 2022

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

Researchers reviewed and analyzed data from SARS-CoV-2 serosurveys supported by the United States Centers for Disease Prevention and Control in the low- and middle-income countries.

6 Jun 2022

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Breast cancer and type 2 diabetes would seem to be distinctly different diseases, with commonality only in their commonality.

30 May 2022

HMA therapy for patients with myelodysplastic syndrome could potentially activate a sleeping oncogene

Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) - a group of disorders where there is insufficient production of healthy mature blood cells in the bone marrow - and increasingly in other diseases, but their mechanism of action remains unclear.

26 May 2022

Hepatitis B News and Research

Latest Hepatitis B News and Research

CDC data shows a sharp decrease in HIV testing during first year of COVID-19 pandemic

New tissue model helps trace the steps involved in liver regeneration

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Chemically modified rocaglates have a stronger effect against viral replication

Simple blood test can predict liver cancer risk in NAFLD patients

Researchers identify the role of TREM2-positive macrophages in non-alcoholic fatty liver disease

UB program secures $12.8 million to improve the quality of global HIV research

Obesity causes COVID vaccines to lose their efficacy more rapidly

Will the US overcome its covid complacency even as the threat returns?

Study shows alarming trends in mortality from alcoholic cirrhosis in the U.S.

As Biden fights overdoses, harm reduction groups face local opposition

Multi-national scientific task force needed to monitor zoonotic viruses long-term

Covid funding pries open a door to improving air quality in schools

The potential role of Ginkgo biloba L. folium extract in the management of COVID-19

Co-circulation of adenovirus 40/41 and SARS-CoV-2 and emergence of hepatitis cases in children

Study investigates SARS-CoV-2 escape from nirmatrelvir

Etiologies of liver cancer are changing and the prognosis is mixed, study says

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

HMA therapy for patients with myelodysplastic syndrome could potentially activate a sleeping oncogene

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Hepatitis B News and Research

Latest Hepatitis B News and Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in